[
  {
    "ts": null,
    "headline": "Madison Sustainable Equity Fund Q4 2024 Investment Strategy Letter",
    "summary": "The S&P 500 ended 2024 with a 25% gain for the year. This marks the second consecutive year of gains exceeding 25% and the third such occurrence in the past four years.",
    "url": "https://finnhub.io/api/news?id=03de51df45863f6ef7a5d23f5e7b4c62c20e182f856ac8ddd40b344488931e86",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740089880,
      "headline": "Madison Sustainable Equity Fund Q4 2024 Investment Strategy Letter",
      "id": 132824708,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1367307631/image_1367307631.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "The S&P 500 ended 2024 with a 25% gain for the year. This marks the second consecutive year of gains exceeding 25% and the third such occurrence in the past four years.",
      "url": "https://finnhub.io/api/news?id=03de51df45863f6ef7a5d23f5e7b4c62c20e182f856ac8ddd40b344488931e86"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=96fc38657ffb5af6b0877e922a3acb44415eb47574443f8be21d453398b7ca66",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740069480,
      "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 132838323,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=96fc38657ffb5af6b0877e922a3acb44415eb47574443f8be21d453398b7ca66"
    }
  }
]